Tauns Laboratories (TSE:197A) Total Liabilities: 円26,793 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
14 GF Score
Price 円484.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Total Liabilities?

Tauns Laboratories TSE:197A -0.82% 14 Total Liabilities is 円26,793 Mil as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 6 warning signs investors should review.

Tauns Laboratories's Total Liabilities for the quarter that ended in Dec. 2025 was 円26,793 Mil.

Tauns Laboratories's quarterly Total Liabilities increased from Jun. 2025 (円19,097.63 Mil) to Sep. 2025 (円23,565.68 Mil) and increased from Sep. 2025 (円23,565.68 Mil) to Dec. 2025 (円26,792.66 Mil).

Tauns Laboratories's annual Total Liabilities increased from Jun. 2023 (円9,842.29 Mil) to Jun. 2024 (円15,594.57 Mil) and increased from Jun. 2024 (円15,594.57 Mil) to Jun. 2025 (円19,097.63 Mil).

Tauns Laboratories Total Liabilities Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Total Liabilities Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Total Liabilities
12,911.78 9,842.29 15,594.57 19,097.63

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,963.09 19,097.63 23,565.68 26,792.66 25,138.44
TSE:197A
14GF Score
Tauns Laboratories Inc TSE:197A
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tauns Laboratories's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9529.874+(8809.081+568.309
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+190.363+0)
=19,098

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=36515.294-17417.667
=19,098

Tauns Laboratories's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13148.932+(12868.088+567.989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+207.646+0)
=26,793

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=44198.627-17405.972
=26,793

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円26,793 Mil mean?
Tauns Laboratories (TSE:197A) has a Total Liabilities of 円26,793 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Tauns Laboratories and its competitors.
Is Tauns Laboratories' Total Liabilities too high?
Tauns Laboratories' current Total Liabilities is 円26,793 Mil. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Total Liabilities compare to ISRG and BDX?
Tauns Laboratories' Total Liabilities of 円26,793 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Tauns Laboratories and its competitors. Tauns Laboratories's current Total Liabilities is 円26,793 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Total Liabilities of 円26,793 Mil. The current Total Liabilities is 円26,793 Mil. Tauns Laboratories' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Total Liabilities is 円26,793 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score

Get the complete analysis for TSE:197A

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円484.00
Price